On Demand 2019 Saturday General Sessions

This collection covers general sessions from Saturday's program. This includes plenaries, symposia, and workshops. The sessions listed below are included in this package:

  • Presidential Plenary Session:  Adapting to New Evidence
  • Practical Use and Effectiveness of New Digital Health Technologies in Effective Treatment of Asthma
  • Prevention of Allergic Conditions: What Conversations to Have with Expecting Parents
  • The Challenges of Infant Food Allergy and Anaphylaxis
  • When Drugs Go Wild!
  • Advances in the Care of Patients with Common Variable Immune Deficiency (CVID)
  • Evolution of Food Allergy Therapies
  • Integrative Approaches to Office Health: Improving Patient Outcomes
  • New Frontiers: COPD, ACO, and Adults with Wheezing
  • Racial, Ethnic, and Socioeconomic Disparities in Food Allergy
  • The Changing Face of an Allergy Practice 
  • Cannabis in 2019:  Navigating Our Patients Through Facts and Misconceptions
  • Cough Across the Ages
  • Coding and Governmental Regulations Update
  • The Difficult to Control Atopic Dermatitis
  • The Updated EoE Guidelines - Whose Disease is it Anyway?

 

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 21.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Of the AMA PRA Category 1 Credits™ listed above, the ABAI has designated a maximum of 3 credits as meeting the requirements for MOC Part II Self-Assessment.

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

  • Practicing allergist/immunologists
  • Allergy/immunology Fellows-in-Training
  • Physician assistants
  • Nurses and advanced practice nurses
  • Allied health professionals
  • Primary care physicians
  • Other medical professionals

Learning Objectives

Upon completion of this session, participants should be able to:

  • Apply evidence surrounding medical treatment and elimination diets in the management of patients with eosinophilic esophagitis.
  • Identify patients at risk for having red meat allergy.
  • Appreciate the role of epithelial dysfunction in the pathophysiology of asthma.
  • Explain how the use of new digital technologies help risk-assess the poorly controlled asthma patient.
  • Assess in a patient with uncontrolled asthma the potential use of new digital technology aids in improving outcomes.
  • Review the use of new technological aids in monitoring patients with severe uncontrolled asthma.
  • Determine which patients referred to them for diagnosis of food allergy require an oral challenge to confirm or refute the same.
  • Perform an oral challenge in their office with confidence and supported by best evidence.
  • Diagnose and manage infant anaphylaxis.
  • Understand the evidence surrounding interventions in expectant mothers and newborns that attenuate the development of allergic conditions.
  • Implement active conversations and anticipatory guidance with expecting parents.
  • Appreciate the various forms of misinformation parents receive from online resources, friends and family members.
  • Describe the histopathology of severe cutaneous drug eruptions.
  • Recognize the appearance of severe cutaneous drug eruptions.
  • Conduct skin testing, challenges or desensitization.
  • Understand how to assess lung function in CVID patients.
  • Identify the role of genetic diagnosis in the care and treatment of patients with CVID.
  • Recognize the role of biologics for treating complications of CVID.
  • Differentiating OIT from EPIT efficacy and safety.
  • Understand impediments for implementation of these therapies.
  • Identify frequently asked questions regarding these therapies.
  • Outline the unhealthy habits in their A/I clinics that lead to physician and clinical team burnout and poor patient outcomes.
  • Identify tools to help navigate the chaotic daily life of an allergy clinic with proven integrative medicine techniques to benefit the entire office team.
  • Understand how a healthy provider and office improves patient outcomes through evidence-based literature review.
  • Categorize the treatment of COPD patients in an allergy/immunology practice setting, utilizing GOLD Guidelines.
  • Identify and treat patients with asthma-COPD overlap (ACO).
  • Identify COPD patients who may benefit from immunodeficiency workup and treatment.
  • Identify racial and ethnic disparities in food allergy prevalence.
  • Describe socioeconomic disparities in food allergy.
  • Understand potential differences in values clarification among racially and ethnically diverse food-allergic populations.
  • Recognize how cannabis legalization impacts patient perceptions and use of the drug.
  • Identify the effects of cannabis on the lungs.
  • Recognize the potential symptoms and nuances of allergic sensitization to cannabis.
  • Understand the role of the varied cough receptors in the pathogenesis of cough.
  • Evaluate a patient with cough.
  • Explain the mechanisms of action of therapeutic agents in the treatment of cough.
  • Describe coding changes and updates relevant to allergy practice.
  • Describe governmental and legislative updates relevant to allergists.
  • Identify best-practice strategies for steroid, PPI and dietary management in EoE.
  • Identify best-practice strategies for biologics and emerging potential therapies management in EoE.
  • Identify best-practice strategies for shared management between GI and allergy in the care of patients with EoE.
Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma & Immunology (ACAAI) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, and/ or evaluation relevant to a CME activity. Disclosed information is reviewed in advance in order to manage and resolve any potential conflicts of interest. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations.

Specific disclosure information for the 2019 Annual Meeting is available online and via the meeting app

Course summary
Available credit: 
  • 21.50 AMA PRA Category 1 Credit™
  • 21.50 Attendance
  • 3.00 MOC
Course opens: 
12/01/2019
Course expires: 
11/30/2022
Rating: 
0

Andrew Alexis, MD, MPH

William C. Anderson, MD

Susan R. Bailey, MD, FACAAI

Aleena Banerji, MD

Joseph A. Bellanti, MD, FACAAI

Bruce Bender, PhD

Leonard Bielory, MD, FACAAI

J. Andrew Bird, MD, FACAAI

Mark Boguniewicz, MD, FACAAI

Hannelore A. Brucker, MD, FACAAI

William Calhoun, MD, FACAAI

James Carmody, PhD

Warner W. Carr, MD, FACAAI

Mariana C. Castells, MD, PhD, FACAAI

Mario Castro, MD, MPH

Edmond S. Chan, MD

Jared Darveaux, MD

Anne K. Ellis, MD, MSc, FACAAI

Nabeel Farooqui, MD, FACAAI

Stanley M. Fineman, MD, MBA, FACAAI

 Bill Finerfrock

David M. Fleischer, MD, FACAAI

Michael B. Foggs, MD, FACAAI

Lisa R. Forbes, MD

Alan B. Goldsobel, MD, FACAAI

Matthew Greenhawt, MD, MSc, MBA, FACAAI

Justin C. Greiwe, MD, FACAAI

Gary N. Gross, MD, FACAAI

Ruchi Gupta, MD, MPH

Nicola A. Hanania, MD, MS

Angela D. Hogan, MD, FACAAI

Stephen Holgate, MD, FACAAI

Randy J. Horwitz, MD, PhD

Stephen A. Imbeau, MD, FACAAI

Jeremy S. Katcher, MD, FACAAI

Rohit K. Katial, MD, FACAAI

Brian T. Kelly, MD, MA

Kevin Joseph Kelly, MD

David A. Khan, MD, FACAAI

Lisa J. Kobrynski, MD, MPH, FACAAI

Bruce J. Lanser, MD, FACAAI

Michael Levin, MD, PhD, FACAAI

Donald Y. Leung, MD, PhD, FACAAI

James T. Li, MD, PhD, FACAAI

Jay A. Lieberman, MD, FACAAI

Aidan A. Long, MD

Todd A. Mahr, MD, FACAAI

Bryan L. Martin, DO, FACAAI

Kevin P. McGrath, MD, FACAAI

Kevin R. Murphy, MD, FACAAI

David R. Naimi, DO

Anil Nanda, MD, FACAAI

Maeve E. O'Connor, MD, FACAAI

Princess Ogbogu, MD, FACAAI

John J. Oppenheimer, MD, FACAAI

Elena E. Perez, MD

Rachel Peters, MPH, PhD

Benjamin Prince, MD, MSci

Nikita Raje, MBBS, MSc

Allison C. Ramsey, MD, FACAAI

Matthew Rank, MD, FACAAI

Melinda M. Rathkopf, MD, FACAAI

John M. Routes, MD, FACAAI

Michael R. Rupp, MD, FACAAI

Marcus Shaker, MD, MSc, FACAAI

Meagan W. Shepherd, MD, FACAAI

Mandel R. Sher, MD, FACAAI

William S. Silvers, MD, FACAAI

Mark C. Stahl, DO, FACAAI

David R. Stukus, MD, FACAAI

James L. Sublett, MD, FACAAI

J. Wesley Sublett, MD, MPH, FACAAI

James M. Tracy, DO, FACAAI

Janna M. Tuck, MD, FACAAI

Carina Venter, PhD, RD

Brian P. Vickery, MD

Dana V. Wallace, MD, FACAAI

Julie Wang, MD, FACAAI

Cherie Y. Zachary, MD, FACAAI

Myron J. Zitt, MD, FACAAI

Available Credit

  • 21.50 AMA PRA Category 1 Credit™
  • 21.50 Attendance
  • 3.00 MOC

Accreditation Period

Course opens: 
12/01/2019
Course expires: 
11/30/2022
Please login or create an account to take this course.